This webinar will discuss the global implications of the COVID-19 economic impact on developing and low-income countries, with Africa as an anchor.
Date
Location
Contact
Annual retreat for Centers of Excellence leadership to meet with each other and the Dean's Office to share and discuss concerns and ideas. Event details: Friday, March 27, 2020 - 10 a.m.-3 p.m. - 2333 VMH. An agenda will be emailed prior to the event.
Date
Location
Contact
Improving Access To Banking Without Sacrificing Profits
New research explores a successful bank making an impact in poor, rural areas in Africa.
CFP Event Explores Diversity and the Bottom Line
When it comes to diversity, the investment industry has a ways to go. That fact, while well known, was further illuminated this month in a survey from the Diverse Asset Managers Initiative (DAMI) and discussed in “Diversity and the Bottom Line,” a webcast hosted by the Center for Financial Policy at the University of Maryland’s Robert H. Smith School of Business.
How Maryland Smith Is Helping the FDA Think About Drug Manufacturing and Risk
Pandemic-era disruptions underscored a troubling reality in the pharmaceutical industry – an outsized reliance on foreign manufacturers for the raw ingredients for drugs sold in the United States. It’s a situation that exposes Americans to numerous risks – operational, financial, geopolitical and environmental. As concerns mount about those risks, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ) is looking to the University of Maryland’s Robert H. Smith School of Business for help with answers.
Fed’s Quarles Discusses Global Financial Stability and Data Gaps
When business scholars examine what transpired in the markets in 2020, in the midst of the COVID-19 pandemic, one of the things they’ll study is financial markets stability and the influence of data gaps.
Investors and ESG
In ‘The Second Objective Function,’ CFP launches a free webinar series that explores the environmental, social and corporate governance questions that are most pressing for organizations and investors today. Can a firm’s level of CO2 emissions predict the level of returns for its shareholders?